MyFinsight
Home
Blog
About
Back
Income Statement
DiaMedica Therapeutics Inc. (DMAC)
DiaMedica Therapeutics Inc. (DMAC)
source: myfinsight.com
Comprehensive loss
-$10,150K
(-31.51%↓ Y/Y)
Net loss
-$10,139K
(-31.69%↓ Y/Y)
Unrealized loss (gain) on
marketable securities
-$11K
(42.11%↑ Y/Y)
Loss before income
tax expense
-$10,132K
(-31.70%↓ Y/Y)
Income tax expense
$7K
(16.67%↑ Y/Y)
Other income, net
$366K
(16.56%↑ Y/Y)
Operating loss
-$10,498K
(-31.11%↓ Y/Y)
Research and development
$8,153K
(40.04%↑ Y/Y)
General and
administrative
$2,345K
(7.32%↑ Y/Y)
Back